Skip to main content
logo
Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
104.01
+0.03 (0.03%)
At close: May 29, 2026, 4:00 PM EDT
104.00
-0.01 (-0.01%)
After-hours: May 29, 2026, 7:54 PM EDT

Inhibrx Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-130.19-140.061,688-241.36-145.23-81.77
Depreciation & Amortization
2.352.482.291.191.231.2
Stock-Based Compensation
11.3411.1458.5224.8520.4515.05
Other Adjustments
4.54.25-1,9956.675.092.72
Change in Receivables
0.050.240.36-0.520.62-0.14
Changes in Accounts Payable
-0.13-3.317.92.11-0.71-4.64
Changes in Accrued Expenses
-17.43-4.3635.8826.077.6-3.74
Changes in Unearned Revenue
----0.17-1.98-1.67
Changes in Other Operating Activities
-2.39-0.2-2.09-12.15-2.38-7.33
Operating Cash Flow
-131.93-129.79-194.41-193.31-115.3-80.32
Capital Expenditures
-0.01-0.03-2.6-4.59-0.69-0.86
Sale of Property, Plant & Equipment
-0---0.06
Investing Cash Flow
-0.01-0.03-2.6-4.59-0.69-0.81
Long-Term Debt Issued
74.9999.97--128.8639.99
Net Long-Term Debt Issued (Repaid)
74.9999.97--128.8639.99
Issuance of Common Stock
0.821.6171.68202.32130.1344.16
Net Common Stock Issued (Repurchased)
0.821.6171.68202.32130.1344.16
Other Financing Activities
--0.13--0.36-0.44-0.38
Financing Cash Flow
77.07101.4571.68201.96258.5583.77
Net Cash Flow
-26-28.38-125.334.06142.562.64
Free Cash Flow
-131.94-129.83-197.01-197.9-115.99-81.19
FCF Margin
-10148.80%-9986.54%-98503.00%-10994.60%-5291.38%-1122.76%
Free Cash Flow Per Share
-8.50-8.38-13.15-16.80-2.89-2.14
Levered Free Cash Flow
-72.81-45.51,739-230.53-13.28-58.82
Unlevered Free Cash Flow
-140.67-140.43-280.07-206.76-126.04-93.61
SEC Filings: 10-K · 10-Q